moventig
AstraZeneca licenses European rights to constipation drug for $70m
March 1, 2016Manufacturing and Production, Sales and Marketing AstraZeneca, EU, Japan, Luke Miles, ProStrakan Group, constipation drug, moventig
AstraZeneca said on Tuesday it has agreed to licence rights to its constipation drug Moventig to Japan’s ProStrakan Group for …
AstraZeneca’s Moventig now available through NHS
October 9, 2015Medical Communications, Research and Development, Sales and Marketing AstraZeneca, moventig
AstraZeneca has announced that Moventig (naloxegol) has been made available for adult patients with opioid-induced constipation (OIC) in England and …
AstraZeneca constipation drug gets EU nod
December 9, 2014Sales and Marketing AstraZeneca, KODIAC, NKTR-118, PAMORA, moventig, naloxegol
AstraZeneca’s opioid-induced constipation drug Moventig has been approved by the European Commission. The first once-daily PAMORA tablet to be given …
Latest content
